Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Tenaya Therapeutics Inc (TNYA)

Tenaya Therapeutics Inc (TNYA)
0.5201 -0.0458 (-8.09%) 11:36 ET [NASDAQ]
0.5201 x 2,200 0.5232 x 500
Realtime by (Cboe BZX)
0.5201 x 2,200 0.5232 x 500
Realtime 0.5280 -0.0379 (-) 09:28 ET
Quote Overview for Thu, Apr 3rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.5016
Day High
0.5300
Open 0.5150
Previous Close 0.5659 0.5659
Volume 1,221,482 1,221,482
Avg Vol 4,658,235 4,658,235
Stochastic %K 13.49% 13.49%
Weighted Alpha -86.41 -86.41
5-Day Change -0.1791 (-25.89%) -0.1791 (-25.89%)
52-Week Range 0.3941 - 5.1000 0.3941 - 5.1000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 49,563
  • Shares Outstanding, K 87,583
  • Annual Sales, $ 0 K
  • Annual Income, $ -111,130 K
  • EBIT $ -116 M
  • EBITDA $ -108 M
  • 60-Month Beta 2.98
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.46
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.32
  • Most Recent Earnings $-0.28 on 03/10/25
  • Next Earnings Date 05/13/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 354.13% ( -0.79%)
  • Historical Volatility 239.28%
  • IV Percentile 93%
  • IV Rank 55.53%
  • IV High 626.84% on 02/28/25
  • IV Low 13.65% on 07/12/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 11
  • Volume Avg (30-Day) 363
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 12,440
  • Open Int (30-Day) 12,149

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.18
  • Number of Estimates 7
  • High Estimate -0.14
  • Low Estimate -0.31
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +55.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3941 +30.09%
on 03/04/25
Period Open: 0.9469
0.7389 -30.61%
on 03/14/25
-0.4342 (-45.85%)
since 03/03/25
3-Month
0.3941 +30.09%
on 03/04/25
Period Open: 1.5200
1.6300 -68.55%
on 01/07/25
-1.0073 (-66.27%)
since 01/03/25
52-Week
0.3941 +30.09%
on 03/04/25
Period Open: 4.7900
5.1000 -89.95%
on 04/04/24
-4.2773 (-89.30%)
since 04/03/24

Most Recent Stories

More News
Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAKâ„¢-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting

TNYA : 0.5201 (-8.09%)
Top 3 Insider Stock Buys in March—Are They Still Good in April?

Insider buying of stocks like Matador Resources, Tenaya Therapeutics, and FirstSun picked up in March and points to value for investors.

MTDR : 45.12 (-13.61%)
TNYA : 0.5201 (-8.09%)
FSUN : 35.67 (-2.25%)
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models

TNYA : 0.5201 (-8.09%)
Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session

TNYA : 0.5201 (-8.09%)
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.

TNYA : 0.5201 (-8.09%)
CSCI : 2.86 (-2.85%)
MLYS : 13.88 (-0.86%)
SWTX : 43.38 (-6.75%)
MGX : 1.2750 (-4.14%)
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

TNYA : 0.5201 (-8.09%)
Tenaya Therapeutics Announces Pricing of Public Offering

TNYA : 0.5201 (-8.09%)
Tenaya Therapeutics Announces Proposed Public Offering

TNYA : 0.5201 (-8.09%)
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences

TNYA : 0.5201 (-8.09%)
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine

TNYA : 0.5201 (-8.09%)

Business Summary

Tenaya Therapeutics Inc. is a biotechnology company. It discovers, develop and deliver curative therapies which address the underlying causes of heart disease. The company's product platform consist Gene Therapy, Cellular Regeneration and Precision Medicine. Tenaya Therapeutics Inc. is based in SOUTH...

See More

Key Turning Points

3rd Resistance Point 0.6284
2nd Resistance Point 0.5984
1st Resistance Point 0.5821
Last Price 0.5201
1st Support Level 0.5358
2nd Support Level 0.5058
3rd Support Level 0.4895

See More

52-Week High 5.1000
Fibonacci 61.8% 3.3023
Fibonacci 50% 2.7471
Fibonacci 38.2% 2.1918
Last Price 0.5201
52-Week Low 0.3941

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades